Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

Launched by ACUTE LEUKEMIA FRENCH ASSOCIATION · Mar 1, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at adults with a type of blood cancer called Acute Myeloid Leukemia (AML). Over the past fifteen years, there have been many new ways to diagnose and treat AML, which means that each patient's experience can be quite different. The study aims to gather more information about these different patient journeys, particularly focusing on those who are newly diagnosed or have had prior treatments for AML.

To be eligible for this study, you need to be at least 18 years old and have been diagnosed with AML that hasn't been treated yet, or you may also qualify if you've had treatment before. It's important to note that certain types of leukemia, like acute promyelocytic leukemia, are not included in this study. If you decide to participate, you won’t receive any new treatments as part of the study; instead, researchers will collect information about your health and treatment options. This study is currently recruiting participants, and if you're interested, you can discuss it with your healthcare provider to see if it might be a good fit for you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient aged 18 years old or more
• • Patient with newly diagnosed previously untreated de novo, secondary or therapy-related AML
• • Patients with R/R de novo, secondary or therapy-related AML
• • Patient with Health insurance
• Exclusion Criteria:
• • Acute promyelocytic leukemia
• • AML which is not morphologically proven (patients with granulocytic sarcoma may be included)
• • For newly diagnosed AML: previous treatment of leukemia apart from hydroxyurea. Previous anti leukemia treatments are allowed if they were administered before the diagnosis of AML to treat a MDS, MPN, MPN/MDS or CML
• • Opposition of the patient to participate to this non-interventional study
• • More specific eligibility criteria might be requested to enter some study modules